|
PROGRAM COMMITTEES
|
Session I: Diabetes: Epidemiology, Pathophysiology and Socioeconomic Burden
CHAIR
Paul Zimmet, MD
Baker IDI Heart and Diabetes Institute
Melbourne, Australia
COMMITTEE
George Alberti, MD
Imperial College
London, UK
Takashi Kadowaki, MD
University of Tokyo
Tokyo, Japan
Bernard Zinman, MD
University of Toronto
Ontario, Canada
|
Session II: Conventional Diabetes Therapies:
Outcomes and Limitations
CHAIR
Harold Lebovitz, MD
SUNY Downstate Medical Center
New York, NY
COMMITTEE
Stephanie Amiel, MD
King’s College London
London, UK
John Buse, MD
University of North Carolina
Chapel Hill, NC
David Simmons, MD
Addenbrooke Hospital
Cambridge, UK
|
|
ASMBS-Sponsored Session III:
Bariatric Surgery: Diabetes
and Metabolic Outcomes
CHAIR
Philip Schauer, MD
Cleveland Clinic
Cleveland, OH
COMMITTEE
John Dixon, MD
Monash University
Clayton, Australia
Michel Gagner, MD
Mt. Sinai Medical Center
Miami, FL
|
Session IV: Gastrointestinal Surgery to
Treat Diabetes in Patients Who Are Not Severely Obese (BMI <35)
CHAIR
Walter Pories, MD
East Carolina University
Greenville, NC
COMMITTEE
Ricardo Cohen, MD
Hospital Sao Camilo
Sao Paulo, Brazil
Geltrude Mingrone, MD
Catholic University
Rome, Italy
|
|
Session V: Gastrointestinal Surgery and
Diabetes in Adolescents
CHAIR
Francine Kaufman, MD
Keck School of Medicine-USC
Los Angeles, CA
COMMITTEE
Thomas Inge, MD
University of Cincinnati
Cincinnati, OH
Meg Zeller, MD
University of Cincinnati
Cincinnati, OH
|
Session VI: Mechanisms of
Surgical Control of Diabetes
CHAIR
David Cummings, MD
University of Washington
Seattle, WA
COMMITTEE
Judith Korner, MD
Columbia University
New York, NY
Carel Le Roux, MD
Imperial College
London, UK
April Strader, Ph.D.
University of Southern Illinois
Springfield, IL
|
|
Session VII: Weighing Research Priorities
in an Era of Constraints
CHAIR
Jesse Roth, MD
Albert Einstein College of Medicine
New York, NY
COMMITTEE
Domenico Accili, MD
Columbia University
New York, NY
Allison Goldfine, MD
Harvard Medical School
Boston, MA
|
Session VIII: Novel Gastrointestinal
Interventional Therapies
CHAIR
Lee Kaplan, MD
Harvard Medical School
Boston, MA
COMMITTEE
Christopher Sorli, MD
University of Montana
Missoula, MT
Manuel Galvao, MD
Gastro Obeso Center
Sao Paulo, Brazil
Jeffrey Milsom, MD
Weill Cornell Medical College
New York, NY
|
|
Session IX:
Clinical and Research Recommendations for Diabetes Surgery:
The Rome Consensus Conference
CHAIR
Francesco Rubino
Weill Cornell Medical College
New York, NY
COMMITTEE
David Cummings, MD
University of Washington
Seattle, WA
Lee Kaplan, MD
Harvard Medical School
Boston, MA
Philip Schauer, MD
Cleveland Clinic
Cleveland, OH
|
Session X: The Economics of
Interventional Therapies and
Implications for Public Health
CHAIRS
Ara Darzi, MD
Imperial College
London, UK
COMMITTEE
David Flum
University of Washington
Seattle, WA
Dens Johnston
Imperial College
London, UK
|
|
Session XI: Comprehensive Management
of Patients with Diabetes:
The Role of Interventional Therapies
CHAIRS
Robin Goland, MD
Columbia University
New York, NY
Louis Aronne, MD
Weill Cornell Medical College
New York, NY
COMMITTEE
Francesco Rubino
Weill Cornell Medical College
New York, NY
Jane Seley
NewYork-Presbyterian /
Weill Cornell Medical Center
New York, NY
|
|
|